Company
Acrivon Therapeutics, Inc. (ACRV)
Standardized SEC financial data for Acrivon Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001781174 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-69.2%
Free cash flow
-$65.3M
Current ratio
7.69×
EPS (diluted)
$-2.02
Income statement
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| R&D expense | — | $23.9M | $46.0M | $64.0M | $60.0M |
| SG&A expense | — | $8.7M |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | — | $100.0M | $29.9M | $36.4M | $40.0M | $41.7M |
| Total current assets |
Cash flow
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | -$14.0M | -$30.1M | -$42.6M | -$65.7M | -$63.7M |
| Capital expenditures | $238K | $2.2M |
Get ACRV data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/ACRV/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/ACRV/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"